Program
Toothpaste
Also written as “Test Fluoride Treatment (0.454% SnF) (Investigational Toothpaste)”, “Marketed Toothpaste” and “Colgate Total Clean Mint”.
Its studies are mostly in Gingivitis · Dental Caries · COVID-19, led by 3 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Procter and Gamble | 20 open or running | phase 4since May 1, 2019 | May 1, 2019 | none ahead |
| Church & Dwight | 10 open or running | no phasesince Feb 11, 2026 | Feb 11, 2026 | none ahead |
| Colgate Palmolive | 10 open or running | phase 3since Apr 25, 2021 | Apr 25, 2021 | none ahead |
Also a collaborator on its studies: therametrics.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- May 1, 2019First studies: 2 phase 4 studies in GingivitisNew to Procter and GambleProcter and Gamble · NCT03936569, NCT03936556
- Apr 25, 2021Colgate Palmolive's first study: phase 3 study in COVID-19New to Colgate PalmoliveColgate Palmolive · NCT04864925 · 46 enrolled · United States
- Feb 11, 2026Church & Dwight's first study: no phase study in Dental CariesNew to Church & DwightChurch & Dwight · NCT07419672 · 31 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07419672Dental Caries · United States | – | Completed | Church & Dwight | Nov 21, 2024 | 31 |
| NCT04864925COVID-19 · United States | 3 | Completed | Colgate Palmolive | Aug 25, 2021 | 46 |
| NCT03936569Gingivitis · United States | 4 | Completed | Procter and Gamble | Jan 25, 2019 | 90 |
| NCT03936556Gingivitis · United States | 4 | Completed | Procter and Gamble | Jun 3, 2018 | 84 |
How it is read
Names in the registry
- “Test Fluoride Treatment (0.454% SnF) (Investigational Toothpaste)”, 1 entry
- “Marketed Toothpaste”, 1 entry
- “Colgate Total Clean Mint”, 1 entry
- “Marketed toothpaste”, 1 entry
Conditions, from the studies’ own filings
- Gingivitis, 2 studies
- Dental Caries, 1 study
- COVID-19, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.